Methylselenol prodrug enhances MDV3100 efficacy for treatment of castration-resistant prostate cancer. [electronic resource]
Producer: 20131031Description: 2225-33 p. digitalISSN:- 1097-0215
- Androgen Antagonists -- pharmacology
- Animals
- Antineoplastic Combined Chemotherapy Protocols
- Benzamides
- Cell Line, Tumor
- Chromatography, Thin Layer
- DNA, Neoplasm -- genetics
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Male
- Methanol -- analogs & derivatives
- Mice
- Mice, Nude
- Nitriles
- Orchiectomy
- Organoselenium Compounds -- pharmacology
- Phenylthiohydantoin -- analogs & derivatives
- Polymerase Chain Reaction
- Prostatic Neoplasms -- drug therapy
- Receptors, Androgen -- genetics
- Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.